Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias F Seidel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|February 18, 2011
Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonistsMatthias F Seidel, Wolfgang Müller
Biomed Research International|March 1, 2018
Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot StudyMara Oleszowsky, Matthias F Seidel
Current Rheumatology Reports|September 6, 2012
Control of arthritis pain with anti-nerve-growth factor: risk and benefitMatthias F Seidel, Nancy E Lane
Rheumatology International|December 21, 2005
Macrophage-like synoviocytes display phenotypic polymorphisms in a serum-free tissue-culture mediumMatthias F Seidel, Franz-Walter Koch, Hans Vetter
Seminars in Arthritis and Rheumatism|June 2, 2009
Nerve growth factor in rheumatic diseasesMatthias F Seidel, Marjeta Herguijuela, Randolf Forkert, et al.
Modern Rheumatology|April 20, 2018
Synovial inflammation analyzed by 3-T magnetic resonance imaging in etanercept-treated patients with rheumatoid arthritis indicates persistent disease activity despite of clinical remission: A pilot studyMara Oleszowsky, Winfried Willinek, Milka Marinova, et al.
Nature Reviews. Rheumatology|November 21, 2020
The evolution of nerve growth factor inhibition in clinical medicineBarton L Wise, Matthias F Seidel, Nancy E Lane
Rheumatology International|July 20, 2007
5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndromeMatthias F Seidel, Gunter F Weinreich, Thomas Stratz, et al.
Frontiers in Immunology|March 18, 2022
Localization of Nerve Growth Factor Expression to Structurally Damaged Cartilaginous Tissues in Human Lumbar Facet Joint OsteoarthritisMatthias F Seidel, Cordula Netzer, Véronique Chobaz, et al.
Lupus|April 23, 2020
Disease activity-dependent expression of nerve growth factor TRKA and P75 receptors on elevated dendritic cells and peripheral leucocytes in patients with systemic lupus erythematosusStefanie Welle, Anna M Wolf, Christian Dernbach, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|February 18, 2011
Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonistsMatthias F Seidel, Wolfgang Müller
Biomed Research International|March 1, 2018
Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot StudyMara Oleszowsky, Matthias F Seidel
Current Rheumatology Reports|September 6, 2012
Control of arthritis pain with anti-nerve-growth factor: risk and benefitMatthias F Seidel, Nancy E Lane
Rheumatology International|December 21, 2005
Macrophage-like synoviocytes display phenotypic polymorphisms in a serum-free tissue-culture mediumMatthias F Seidel, Franz-Walter Koch, Hans Vetter
Seminars in Arthritis and Rheumatism|June 2, 2009
Nerve growth factor in rheumatic diseasesMatthias F Seidel, Marjeta Herguijuela, Randolf Forkert, et al.
Modern Rheumatology|April 20, 2018
Synovial inflammation analyzed by 3-T magnetic resonance imaging in etanercept-treated patients with rheumatoid arthritis indicates persistent disease activity despite of clinical remission: A pilot studyMara Oleszowsky, Winfried Willinek, Milka Marinova, et al.
Nature Reviews. Rheumatology|November 21, 2020
The evolution of nerve growth factor inhibition in clinical medicineBarton L Wise, Matthias F Seidel, Nancy E Lane
Rheumatology International|July 20, 2007
5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndromeMatthias F Seidel, Gunter F Weinreich, Thomas Stratz, et al.
Frontiers in Immunology|March 18, 2022
Localization of Nerve Growth Factor Expression to Structurally Damaged Cartilaginous Tissues in Human Lumbar Facet Joint OsteoarthritisMatthias F Seidel, Cordula Netzer, Véronique Chobaz, et al.
Lupus|April 23, 2020
Disease activity-dependent expression of nerve growth factor TRKA and P75 receptors on elevated dendritic cells and peripheral leucocytes in patients with systemic lupus erythematosusStefanie Welle, Anna M Wolf, Christian Dernbach, et al.
Pageof 2